Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 13, 2013 - Issue 4
Submit an article Journal homepage
53
Views
2
CrossRef citations to date
0
Altmetric
Research Report

Reviewing and piloting methods for decreasing discount rates; someone, somewhere in time

Mehraj BY Parouty Unit of PharmacoEpidemiology & PharmacoEconomics (PE), Antonius Deusinglaan 1, 9713AV Groningen, The Netherlands; Unit of PharmacoEpidemiology & PharmacoEconomics (PE), Antonius Deusinglaan 1, 9713AV Groningen, The Netherlands
,
Daan GM Krooshof Department of Pharmacy, University of Groningen, The Netherlands; Department of Pharmacy, University of Groningen, The Netherlands
,
Tjalke A Westra Department of Pharmacy, University of Groningen, The Netherlands; Department of Pharmacy, University of Groningen, The Netherlands
,
Petros Pechlivanoglou Department of Pharmacy, University of Groningen, The Netherlands; Department of Pharmacy, University of Groningen, The Netherlands
&
Maarten J Postma Unit of PharmacoEpidemiology & PharmacoEconomics (PE), Antonius Deusinglaan 1, 9713AV Groningen, The Netherlands. [email protected]; Unit of PharmacoEpidemiology & PharmacoEconomics (PE), Antonius Deusinglaan 1, 9713AV Groningen, The Netherlands. [email protected]
Pages 523-547 | Published online: 09 Jan 2014

References

  • National Institute for Health and Clinical Excellence (NICE). Updated Guide to the Methods of Technology Appraisal. NICE, London, UK (2008).
  • Hakkaart-van Roijen I, Tan S, Bouwmans CAM. Handleiding voor Kostenonderzoek: Methoden En Standaard Kostprijzen voor Economische Evaluaties in de Gezondheidszorg (in Dutch). CVZ, Diemen, The Netherlands (2010).
  • Postma MJ, Parouty M, Westra TA. Accumulating evidence for the case of differential discounting. Expert Rev. Clin. Pharmacol. 6, 1–3 (2013).
  • Schwappach LBD. The economic evaluation of prevention; let’s talk about values and the case of discounting. Int. J. Public Health 52, 335–336 (2007).
  • Gravelle H, Smith HD. The practice of discounting in economic evaluations of health care interventions. Int. J. Technol. Assess Health Care 17, 236–243 (2001).
  • Van Hout AB. Discounting costs and effects: a reconsideration. Health Econ. 7, 581–594 (1998).
  • Green L, Fristoe N, Myerson J. Temporal discounting and preference reversals in choice between delayed outcomes. Psychon. Bull. Rev. 1, 383–389 (1994).
  • Kirby KN, Marakovic NN. Modeling myopic decisions: evidence for hyperbolic delay-discounting within subjects and amounts. Organ. Behav. Hum. Decis. Process 64, 22–30 (1995).
  • Cairns AJ, van der Pol MM. Saving future lives: a comparison of three discounting models. Health Econ. 6, 341–350 (1997).
  • Cairns AJ, van der Pol MM. Valuing future private and social beneits: the discounted utility model versus hyperbolic discounting models. J. Econ. Psychol. 21, 191–205 (2000).
  • Bobinac A, Brouwer W, van Exel J. Discounting future health gains: an empirical enquiry into the influence of growing life expectancy. Health Econ. 20, 111–119 (2011).
  • Frederick S, Loewenstein G, O’Donoghue T. Time discounting and time preference: a critical Review. J. Econ. Lit. 40, 351–401 (2002).
  • Samuelson P. A note on measurement of utility. Rev. Econ. Stud. 4, 155–161 (1937).
  • Harvey MC. Value functions for infinite period planning. Manag. Sci. 32, 1123–1139 (1986).
  • Loewenstein FG, Prelec D. Anomalies in intertemporal choice: evidence and an interpretation. Q. J. Econ. 107, 573–597 (1992).
  • Mazur JE. An adjustment procedure for studying delayed reinforcement. In: Quantitative Analyses of Behavior (Vol. 5). The Effect of Delay and Intervening Events on Reinforcement Value. Commons ML, Mazur JE, Nevin JA, Rachlin H (Eds). Erlbaum, Hillsdale, NJ, USA (1987).
  • Albrecht A, Weber M. Hyperbolic discounting models in prescriptive theory of intertemporal choice. Z. Wirtsch Sozialwiss 115, S535–S568 (1995).
  • Treasury HM. Appraisal and Evaluation in Central Government (The Green Book). Stationery Office, London, UK (1997).
  • Bazelon C, Smetters K. Discounting in the long term. Loyola Los Angel Law Rev. 35, 277–292 (2001).
  • Beutels P, Scuffham PA, MacIntyre CR. Funding of drugs: do vaccines warrant a different approach? Lancet Infect. Dis. 8, 727–732 (2008).
  • Cropper LM, Aydede KS, Portney RP. Rates of time preference for saving lives. Am. Econ. Rev. 82, 460–472 (1992).
  • Rae J. The Sociological Theory of Capital (Reprint of Original 1834 Edition). Macmillan, London, UK (1834).
  • Fisher I. Theory of Interest. Macmillan, NY, USA (1930).
  • Ramsey PF. Philosophical Papers. Cambridge University Press, Cambridge, UK (1990).
  • Von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. Princeton University Press, NJ, USA (1953).
  • Sung Su Y, Gelman A, Hill J et al. Multiple imputation with diagnostics (mi) in R: opening windows into the black box. J. Stat. Software 45, 1–31 (2011).
  • Rubin DB. Multiple Imputation for Nonresponse in Surveys. Wiley & Sons, NY, USA (2009).
  • Pinheiro JC, Bates DM. Mixed-Effects Models in S and S-PLUS. Springer Verlag, NY, USA (2000).
  • Pehlivanoglou P. Applying and Extending Mixed-Effects Models in Health Economics and Outcomes Research. Ximos, Thesis at the University of Groningen, Athens, Greece (2012).
  • Akaike H. A new look at the statistical model identification. IEEE Trans. Automatic Control 19, 716–723 (1974).
  • Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria (2011).
  • Steinberg L, O’Brien L, Cauffman E et al. Age difference in future orientation and delay discounting. Child Dev. 80(1), 28–44 (2009).
  • Chapman GB, Elstein AS. Valuing the future: temporal discounting of health and money. Med. Decis. Making 15, 373–386 (1995).
  • Nord E. Discounting future health benefits: the poverty of consistency arguments. Health Econ. 20, 16–26 (2011).
  • Westra TA, Parouty MBY, Brouwer WB et al. On discounting health gains from Human Papilloma Virus Vaccination. Value Health 15, 562–567 (2012).
  • Keeler EB, Cretin S. Discounting of life-saving and other non-monetary effects. Manag. Sci. 29, 300–306 (1983).
  • Gravelle H, Smith D. Discounting for health effects in cost–benefit and cost–effectiveness analysis. Health Econ. 10, 587–599 (2001).
  • Brouwer WBF, Niessen LW, Postma MJ, Rutten FFH. Need for differential discounting of costs and health effects in cost–effectiveness analyses. BMJ 331, 446–448 (2005).
  • Claxton K, Sculpher M, Culyer A et al. Discounting and cost–effectiveness in NICE – stepping back to sort out a confusion. Health Econ. 15, 1–4 (2006).
  • Gravelle H, Brouwer W, Niessen L, Postma MJ, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ. 16, 307–317 (2007).
  • Klok RM, Brouwer WB, Annemans LJ, Bos JM, Postma MJ. Towards a healthier discount procedure. Expert Rev. Pharmacoeconomics Outcomes Res. 5, 59–63 (2005).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.